Ashley Parich, PA
Medical · Lafayette, LANPI 1295921914
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $898, 2.1 times the $436 reported in 2021.
Across 183 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$444
- Sumitomo Pharma America, Inc.$441
- Exeltis, USA Inc.$421
- Amgen$250
- Pfizer$249
- Astellas Pharma US Inc$237
- plus $1K from 19 others
What the payments were for
- Consulting fees$1755%
- Food & beverage$3,17894%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $444 |
| Sumitomo Pharma America, Inc. | 26 | $441 |
| Exeltis, USA Inc. | 34 | $421 |
| Amgen | 7 | $250 |
| Pfizer | 15 | $249 |
| Astellas Pharma US Inc | 8 | $237 |
| Mayne Pharma Commercial LLC | 7 | $198 |
| Bayer | 10 | $176 |
| Sage Therapeutics, LLC | 8 | $168 |
| Organon | 9 | $143 |
| Daiichi Sankyo Inc. | 6 | $122 |
| Myovant Sciences Inc. | 8 | $121 |
| Hologic Sales And Service, LLC | 3 | $68 |
| Avion Pharmaceuticals | 3 | $57 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Evofem Biosciences, Inc. | 2 | $39 |
| Merck | 2 | $33 |
| Radius Health, Inc. | 1 | $31 |
| Alfasigma USA, Inc. | 1 | $19 |
| Biogen | 1 | $16 |
| BD | 1 | $16 |
| Coopersurgical, Inc. | 1 | $12 |
| Virtus Pharmaceuticals LLC | 1 | $11 |
| Genentech USA, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,367 in reported general payments places this provider in the 80th percentile of 253 medical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 16 | $1,175 |
| Estradiol | 38 | $845 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $460 |
| Alendronate Sodium | 48 | $321 |
| Alprazolam | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other medical in Lafayette
- Thomas BriscoeLafayette$13K
- Celenia StanfordLafayette$7K
- Victoria PlaucheLafayette$6K
- Eric BullerLafayette$6K
- Mary CaseLafayette$6K
- Brittany RamirezLafayette$3K
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.